FL-118 (Canget BioTekpharma)

N/A

Report date: 2025/10/31 18:01:22
NME

Base Information

Drug NameFL-118 (Canget BioTekpharma)
Drug Alias NameFL923FL118FL7724FL926FL762 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProbable ATP-dependent RNA helicase DDX5 inhibitors
TargetsProbable ATP-dependent RNA helicase DDX5
Therapy Area/IndicationsProstatic NeoplasmsHead and Neck NeoplasmsOvarian Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCanget BioTekpharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesCanget BioTekpharma LLC
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsHead and Neck NeoplasmsOvarian Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A